Gang H. An

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020
Tianjin, 301600, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 235 publications

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience.

Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 01, 2026

Tracking tumor and immune remodeling through myeloma therapy.

Tracking tumor and immune remodeling through myeloma therapy.

Journal: Trends in immunology

Published: August 03, 2026

Familial hemophagocytic lymphohistiocytosis presenting initially as autoimmune lymphoproliferative syndrome: a case report

Familial hemophagocytic lymphohistiocytosis presenting initially as autoimmune lymphoproliferative syndrome: a case report

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: July 06, 2026

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

Journal: The New England journal of medicine

Published: June 15, 2026

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Journal: Leukemia

Published: June 09, 2026

Extracellular Vesicles for Therapeutic Applications: A Translational Framework Integrating Sources, Administration Routes, Indications, Quality Control, and Regulatory Systems.

Extracellular Vesicles for Therapeutic Applications: A Translational Framework Integrating Sources, Administration Routes, Indications, Quality Control, and Regulatory Systems.

Journal: International journal of nanomedicine

Published: May 06, 2026

Single-Cell Profiling Identifies SLC2A5-Mediated Fructose Metabolism as a Vulnerability in Primary CNS Lymphoma.

Single-Cell Profiling Identifies SLC2A5-Mediated Fructose Metabolism as a Vulnerability in Primary CNS Lymphoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 10, 2026

Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 27, 2026

Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypes.

Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypes.

Journal: Biomarker research

Published: February 16, 2026

MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications.

MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications.

Journal: Leukemia

Published: December 10, 2025

Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia.

Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia.

Journal: Haematologica

Published: November 19, 2025

Showing 1-12 of 235

Last Updated: 09/26/2026